Vai al contenuto principale della pagina

Toxins and Cancer Therapy



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Snook Adam E Visualizza persona
Titolo: Toxins and Cancer Therapy Visualizza cluster
Pubblicazione: Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica: 1 electronic resource (104 p.)
Soggetto topico: Medicine
Soggetto non controllato: immunotoxin
ribotoxin
α-sarcin
RNase T1
furin
intracellular trafficking
colorectal cancer
botulinum toxin
botulinum neurotoxin
cancer
cancer cells
neuropathic pain
post-surgical pain
parotid gland
submaxillary gland
gustatory hyperhidrosis
sialocele
parotid fistula
immunotherapy
vaccine
immune checkpoint inhibitors
adoptive cell therapy
cytokine therapy
Coley's Toxins
glioblastoma
drug discovery
cytotoxic necrotizing factor type 1
protein purification
recombinant protein production
shiga toxins
Gb3/CD77
apoptosis
ER stress
autophagy
Burkitt lymphoma
Persona (resp. second.): SnookAdam E
Sommario/riassunto: Cancer has been a patient-specific and difficult-to-treat disease for decades, resulting in more deaths since 1900 than all other diseases except cardiovascular diseases. As societies around the world continue to shift towards an aging population, the social and economic burden created by cancer will only rise in the coming decades, necessitating continued improvement in our cancer therapies. Remarkably, in the late 1800s, bone surgeon William Coley serendipitously discovered that bacteria could be administered to patients as an effective (and sometimes toxic) form of cancer therapy known as "Coley's Toxins". His discoveries unknowingly led to two fields of cancer therapy that have been in development for decades and are now leading to significant improvements in therapy for cancer patients: immune-based and toxin-based therapies for cancer. Articles included here discuss the discoveries that emerged from Coley's Toxins that enable us to harness the immune system and microbial toxins to combat cancers, as oncology shifts from a field dominated by chemotherapy for most of the 20th century to biologic therapies that will dominate the 21st century.
Titolo autorizzato: Toxins and Cancer Therapy  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910557123603321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui